Nosocomial Infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran
-
Bahman Poorabbas
,
Jalal Mardaneh
,
Zahra Rezaei
,
Mehdi Kalani
,
Gholamreza Pouladfar
,
Mohammad Hasan Alami
,
Jafar Soltani
,
Ahmad Shamsi-Zadeh
,
Shahram Abdoli-Oskooi
,
Mohammed Jafar Saffar
,
Abdolvahab Alborzi
Abstract
Background and Objective: Antibiotic resistance is increasing, especially in healthcare-associated infections causing significant public health concerns worldwide. National information is required to make appropriate policies, update list of essential drugs for treatment, and evaluate the effects of intervention strategies. A nationwide surveillance of antimicrobial resistant bacteria in nosocomial infections was established in Iran in 2008, so that the data obtained through the surveillance would enable us to construct a database.
Materials and Methods: Seven major teaching hospitals in Shiraz, Tabriz, Sari, Mashhad, Sanandaj, Ahwaz and Isfahan participated in this study. A total of 858 strains isolated from blood and other sterile body fluids were tested. Identification at the species level was performed with conventional biochemical methods and the API system. Susceptibility tests were done using disk diffusion method. The methicillin-resistance in S. aureus (MRSA) was determined by the oxacillin agar screen plate and respective MIC values were assessed using the E-test strips. The confirmatory disk diffusion methods were applied for phenotypic identification of extended-spectrum β- lactamase (ESBL) production for E. coli and K. pneumoniae, according to CLSI guidelines.
Results: Cultivation and re-identification of the strains yielded 858 isolates, consisting of 224 S. aureus, 148 Klebsiella spp., 105 Serratia spp., 146 E. coli, 67 Acinetobacter spp., 38 Enterobacter spp., 95 Pseudomonas spp., 71 P.aeruginosa.35 Stenotrophomonas sp., and 8 other organisms. MRSA was detected in 37.5% of the isolates. No vancomycin-resistant or vancomycin-intermediate resistant S. aureus was detected. With the exception of Acinetobacter and Stenotrophomonas, 85% of the Gram-negative isolates were found to be susceptible in vitro to imipenem. Overall, about 61% of K. pneumoniae and 35% of E. coli isolates were ESBL producing.
Conclusion: Multidrug resistant isolates of Gram-negative organisms and methicillin-resistant strains of S. aureus have been detected in many hospitals in this study.
Karam GH and Heffner JE. Emerging issues in Antibiotic Resistance in Blood-borne Infections. Am J Respir Crit Care Med 2000; 162: 1610-1616.
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance- the need for global solutions. Lancet Infect Dis 2013;13:1057-1098.
Rice LB. Antimicrobial Resistance in Gram-Positive Bacteria. Am J Med 2006; 119(6 Suppl 1):S11-9.
Boucher HW and Ralph Corey G. Epidemiology of Methicillin-Resistant Staphylococcus aureus. Clin Infect Dis 2008; 46:S344-349.
Udobi CE, Obajuluwa AF, and Onaolapo JA.Prevalence and Antibiotic Resistance Pattern of Methicillin-Resistant Staphylococcus aureus from an Orthopaedic Hospital in Nigeria. BioMed Research International 2013; 2013:1-4.
Latif S, Saeed Anwar M and Ahmad I. Bacterial Pathogens Responsible For Blood Stream Infection (Bsi) And Pattern Of Drug Resistance In A Tertiary Care Hospital Of Lahore. Biomedica 2009; 25:101-105.
Poole K. Resistance to β-lactam antibiotics. CMLS 2004; 61: 2200-2223.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-281.
Pasricha J, Koessler T, Harbarth S, Schrenzel J, Camus V, Cohen J, et al. Carriage of extended-spectrum beta- lactamase-producing enterobacteriacae among internal medicine patients in Switzerland. Antimicrob Resist Infect Control 2013; 2:20.
Grundmann H, Hahn A, Ehrenstein B, Geiger K, Just H, Daschner FD. Detection of cross-transmission of multiresistant Gram-negative bacilli and Staphylo- coccus aureus in adult intensive care units by routine typing of clinical isolates. Clin Microbiol Infect 1999;5:355-363.
Clinical and Laboratory Standards Institute (CLSI).2011, M100-S21. Vol. 31 No. 1.
Tamma PD, Girdwood SCT, Gopaul R, Tekle T, Roberts AA, Harris AD, et al. The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae. Clin Infect Dis 2013.
Burwen DR, Banerjee SN, Gaynes RP. Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United-States. J Infect Dis 1994;170:1622-1625.
Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215.
Hanberger H, Garcia-Rodriguez JA, Gobernado M, Gossens H, ilsson LE, Struelens MJ, et al. Enterobacter cloacae were resistant to ceftazidime, according to studies of ICU isolates in the United States between 1987 and 1991. JAMA 1999; 281: 67-71.
Braykov NP, Eber MR, Klein EY, Morgan DJ, Laxminarayan R. Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States,1999-2010. Infect Control Hosp Epidemiol 2013; 34.
Ponsa MJ, Mosquitob S, Gomesa C, del Vallec LJ, Ochoab TJ, Ruiz J. Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru. Trans R Soc Trop Med Hyg 2014; 108: 22-28.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary. Clin Infect Dis 2011; 52: 285-292.
Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae-A Case-Control Study in a Low Prevalence Country. PLoS ONE 2013; 8: e69581.
Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram- Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007. Antimicrob Agents Chemother 2009; 53:3280-3284.
Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States. Antimicrob Agents Chemothert 2006; 50: 2872-2874.
Brooke JS. Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen. Clin Microbiol Rev January 2012; 25: 2-41.
Decker K, Rather PN, Bonomo Federico Perez RA, Hujer AM, Hujer KM, et al. Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51:3471.
Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 2012; 39:105-114.
Katragkou A, Roilides E. Successful Treatment of Multidrug-Resistant Acinetobacter baumannii Central Nervous System Infections with Colistin. J Clin Microbiol 2005; 43: 4916-4917.
Acosta J, Merino M, Viedma E, Poza M, Sanz F, Otero JR, et al. Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis 2011; 17:1064-1067.
Riley TV, Webb SAR, Cadwallader H, Briggs BD, Christiansen L, Bowman RA. Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: Clinical, epidemiological and microbiological features. Pathology 1996; 28: 359-63.
Tuon FF, Gortz LW, Rocha JL. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy. Braz J Infect Dis 2012;16:351-356.
Akpaka PE, Kissoon S, Rutherford C, Swanston WH, Jayaratne P. Molecular epidemiology of methicillin- resistant Staphylococcus aureus isolates from regional hospitals in Trinidad and Tobago. Int J Infec Dis 2007;11: 544-548.
Pourakbari B, Sadr A, Ashtiani MT, Mamishi S, Dehghani M, Mahmoudi S, et al. Five-year evaluation of the antimicrobial susceptibility patterns of bacteria causing bloodstream infections in Iran. J Infect Dev Ctries 2012; 6:120-125.
Anvarinejad M, Japoni A, Rafaatpour N, Mardaneh J, Abbasi P, Amin Shahidi M, et al. Burn patients infected with metallo-beta-lactamase-producing Pseudomonas aeruginosa: Multidrug-resistant strains. Arch Trauma Res 2014; 3:e18182.
Chen CJ, Huang YC. Community-acquired methicillin- resistant Staphylococcus aureus in Taiwan. Microbiol Immunol Infect 2005; 38:376-382.
Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H. Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China. PLoS ONE 2013; 8: e73300.
Mardaneh J, Dallal MM. Isolation, identification and antimicrobial susceptibility of Pantoea (Enterobacter) agglomerans isolated from consumed powdered infant formula milk (PIF) in NICU ward: First report from Iran. Iran J Microbiol 2013; 5:263-267.
Mardaneh J, Soltan-Dallal MM. Isolation and identi- fication of E. cowanii from powdered infant formula in NICU and determination of antimicrobial susceptibility of isolates. Iran J Pediatr 2014; 24: 261-266.
Mardaneh J, Soltan Dallal MM, Taheripoor M, Rajabi Z.Isolation, identification and antimicrobial susceptibility pattern of Tatumella ptyseos strains isolated from powdered infant formula milk consumed in neonatal intensive care unit: First report from Iran. Jundishapur J Microbiol 2014; 7(6):e10608.
| Files | ||
| Issue | Vol 7 No 3 (2015) | |
| Section | Articles | |
| Keywords | ||
| Blood Sterile body fluids Gram negative bacteria Staphylococcus aureus Antimicrobial resistance Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
